Zobrazeno 1 - 10
of 1 615
pro vyhledávání: '"R. Sah"'
Autor:
Vasu R. Sah, Henrik Jespersen, Joakim Karlsson, Lisa M. Nilsson, Mattias Bergqvist, Iva Johansson, Ana Carneiro, Hildur Helgadottir, Max Levin, Gustav Ullenhag, Anders Ståhlberg, Roger Olofsson Bagge, Jonas A. Nilsson, Lars Ny
Publikováno v:
Cancer Research Communications. 3:884-895
Purpose: Patients with metastatic uveal melanoma have limited therapeutic options and high mortality rate so new treatment options are needed. Patients and Methods: We previously reported that patients treated with the PD-1 inhibitor pembrolizumab an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1f61ee2b2a9e060e7ab5e3f00bcbb746
https://doi.org/10.1158/2767-9764.crc-22-0490
https://doi.org/10.1158/2767-9764.crc-22-0490
Publikováno v:
Journal of Agriculture and Forestry University. :209-217
Udder and teat conformations and measurements play a vital role in milk productivity and mastitis resistance in dairy buffaloes. The study was conducted on apparently healthy 24 Murrah buffaloes running on different parities selected from 3 different
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e66356291a9c38620588b2378f8b0f38
https://doi.org/10.3126/jafu.v5i1.48467
https://doi.org/10.3126/jafu.v5i1.48467
Autor:
Lars Ny, Jonas A. Nilsson, Roger Olofsson Bagge, Anders Ståhlberg, Gustav J. Ullenhag, Max Levin, Hildur Helgadottir, Ana Carneiro, Iva Johansson, Mattias Bergqvist, Lisa M Nilsson, Joakim Karlsson, Henrik Jespersen, Vasu R Sah
Figure S3. a) Heat map showing plasma chemokine and cytokine levels pre-treatment to end of study (EOS) in patients with progressive disease (PD) b) Heat map of plasma chemokine levels pre-treatment to EOS in stable disease (SD) patients. c) Heat map
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6097685a6839e4a81802794abbfe1944
https://doi.org/10.1158/2767-9764.22930538
https://doi.org/10.1158/2767-9764.22930538
Autor:
Lars Ny, Jonas A. Nilsson, Roger Olofsson Bagge, Anders Ståhlberg, Gustav J. Ullenhag, Max Levin, Hildur Helgadottir, Ana Carneiro, Iva Johansson, Mattias Bergqvist, Lisa M Nilsson, Joakim Karlsson, Henrik Jespersen, Vasu R Sah
Purpose:Patients with metastatic uveal melanoma have limited therapeutic options and high mortality rate so new treatment options are needed.Patients and Methods:We previously reported that patients treated with the PD-1 inhibitor pembrolizumab and t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ccdda0f37fdea4ebde8dc4703e012e9
https://doi.org/10.1158/2767-9764.c.6628509
https://doi.org/10.1158/2767-9764.c.6628509
Autor:
Lars Ny, Jonas A. Nilsson, Roger Olofsson Bagge, Anders Ståhlberg, Gustav Ullenhag, Max Levin, Hildur Helgadottir, Ana Carneiro, Iva Johansson, Mattias Bergqvist, Lisa M. Nilsson, Joakim Karlsson, Henrik Jespersen, Vasu R. Sah
Kaplan–Meier analysis showing. PFS (A) and OS (B), respectively using pretreatment plasma CCL21 (pg/mL) measurements based on their median values. C, Correlation between CCL21 (pg/mL) and CD3+CCR7+CD45RA+ (% counts) matched patient samples (n = 23)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc75b67b510f17ed10f776715ff10ecd
https://doi.org/10.1158/2767-9764.22930553
https://doi.org/10.1158/2767-9764.22930553
Autor:
Lars Ny, Jonas A. Nilsson, Roger Olofsson Bagge, Anders Ståhlberg, Gustav Ullenhag, Max Levin, Hildur Helgadottir, Ana Carneiro, Iva Johansson, Mattias Bergqvist, Lisa M. Nilsson, Joakim Karlsson, Henrik Jespersen, Vasu R. Sah
IHC magenta showing low mag of CD20 varied staining of TLS-like (borderline-tertiary lymphoid structures) followed by high magnification images of CD20, CD3, CCL21 within serial sections for Pt 2-027 (A), 3-010 (B). Also see Supplementary Fig. S5. Lo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::10a75d21edd9db4a28dfebfdfbf9cde6
https://doi.org/10.1158/2767-9764.22930547
https://doi.org/10.1158/2767-9764.22930547
Autor:
Lars Ny, Jonas A. Nilsson, Roger Olofsson Bagge, Anders Ståhlberg, Gustav J. Ullenhag, Max Levin, Hildur Helgadottir, Ana Carneiro, Iva Johansson, Mattias Bergqvist, Lisa M Nilsson, Joakim Karlsson, Henrik Jespersen, Vasu R Sah
Patient sample information
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::17e63922c664802cab4c606fec26661a
https://doi.org/10.1158/2767-9764.22930517
https://doi.org/10.1158/2767-9764.22930517
Autor:
Lars Ny, Jonas A. Nilsson, Roger Olofsson Bagge, Anders Ståhlberg, Gustav Ullenhag, Max Levin, Hildur Helgadottir, Ana Carneiro, Iva Johansson, Mattias Bergqvist, Lisa M. Nilsson, Joakim Karlsson, Henrik Jespersen, Vasu R. Sah
A, Kaplan–Meier analysis showing PFS of all patients. B, Kaplan–Meier analysis showing OS of all patients except one. C, Swimmer plot showing time on treatment, time to best response, and duration of response in all patients who received at least
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7119e03d01536725f224f7801da5f5f4
https://doi.org/10.1158/2767-9764.22930565.v1
https://doi.org/10.1158/2767-9764.22930565.v1
Autor:
Lars Ny, Jonas A. Nilsson, Roger Olofsson Bagge, Anders Ståhlberg, Gustav Ullenhag, Max Levin, Hildur Helgadottir, Ana Carneiro, Iva Johansson, Mattias Bergqvist, Lisa M. Nilsson, Joakim Karlsson, Henrik Jespersen, Vasu R. Sah
A and B, Kaplan–Meier analysis showing PFS and OS of patients with a wildtype BAP1 status and UV-damaged uveal melanoma genome. PFS (C) and OS (D) analyses comparing patients with GNAQ- or GNA11-mutated uveal melanoma. E, Volcano plot showing diffe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ab30d922a117e7b5b2f22fa0a17d0e7
https://doi.org/10.1158/2767-9764.22930562
https://doi.org/10.1158/2767-9764.22930562
Autor:
Joakim Karlsson, Vasu R. Sah, Roger Olofsson Bagge, Munir Iqbal, Samuel Alsén, Sofia Stenqvist, Alka Saxena, Lars Ny, Lisa M. Nilsson, Jonas A. Nilsson
Uveal melanoma (UM) is a rare melanoma originating in the eye’s uvea, with 50% of patients experiencing metastasis predominantly in the liver. In contrast to cutaneous melanoma, there is only a limited effectiveness of combined immune checkpoint th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3a197c3d3b1285a2129c491b9ea04570
https://doi.org/10.1101/2023.05.16.540908
https://doi.org/10.1101/2023.05.16.540908